Stent companies fight to stay afloat, but patients wary after cap

Following the NPPA decision, some companies have reportedly withdrawn high-priced stents, leading to an artificial shortage of the product.

Source: The Economic Times - February 19, 2017 Category: Consumer Health News Source Type: news